Chronic Kidney Disease Trial, Recruiting (NCT07705269)

Chronic Kidney Disease Trial, Recruiting NCT07705269 Sponsor: Universidad Autonoma de Nuevo Leon Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07705269 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who have end-stage kidney failure and have been receiving hemodialysis (a machine-based kidney treatment) for at least 3 months
People who have been admitted to hospital and need a medical procedure to remove excess fluid from the body for the first time during that hospital stay
People whose ultrasound scan shows clear signs of severe fluid buildup inside the blood vessels, such as fluid visible in the lungs or abnormal blood flow patterns in certain veins
People whose blood pressure is stable and at least 120/80 mmHg at the start of the trial

Who may not be able to join:

People whose blood pressure is below 100/60 mmHg, or who are currently in a state of shock (such as shock caused by heart failure, severe infection, or circulation problems)
People who have recently had a heart attack, have a serious heart valve problem, or have significant fluid buildup around the heart
People with a known long-term lung disease
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +52 8180911271

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07705269

Sponsor: Universidad Autonoma de Nuevo Leon

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +52 8180911271

More information: https://clinicaltrials.gov/study/NCT07705269

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who have end-stage kidney failure and have been receiving hemodialysis (a machine-based kidney treatment) for at least 3 months
People who have been admitted to hospital and need a medical procedure to remove excess fluid from the body for the first time during that hospital stay
People whose ultrasound scan shows clear signs of severe fluid buildup inside the blood vessels, such as fluid visible in the lungs or abnormal blood flow patterns in certain veins
People whose blood pressure is stable and at least 120/80 mmHg at the start of the trial

Who may not be able to join:

People whose blood pressure is below 100/60 mmHg, or who are currently in a state of shock (such as shock caused by heart failure, severe infection, or circulation problems)
People who have recently had a heart attack, have a serious heart valve problem, or have significant fluid buildup around the heart
People with a known long-term lung disease
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universidad Autonoma de Nuevo Leon

Registry

ClinicalTrials.gov

Start date

4 June 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Safety (Incidence of Intradialytic Hypotension - IDH); Ultrasound Efficacy; Clinical Respiratory Efficacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov